PVH Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

PVH Corp ( PVH ). will release its fourth-quarter financial results after the closing bell on Monday, March 31.

Analysts expect the company to report quarterly earnings at $3.22 per share, down from $3.72 per share in the year-ago period. PVH projects quarterly revenue of $2.34 billion, compared to $2.49 billion a year earlier, according to data from Benzinga Pro.

On Feb. 5, PVH declared a quarterly cash dividend of $0.0375 per share payable on March 26, to stockholders of record on March 5.

PVH shares fell 2.9% to close at $64.69 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Citigroup analyst Paul Lejuez maintained a Neutral rating and cut the price target from $123 to $72 on March 25, 2025. This analyst has an accuracy rate of 64%.
  • UBS analyst Jay Sole maintained a Buy rating and lowered the price target from $172 to $160 on March 19, 2025. This analyst has an accuracy rate of 68%.
  • Goldman Sachs analyst Brooke Roach maintained a Buy rating and slashed the price target from $128 to $109 on March 4, 2025. This analyst has an accuracy rate of 61%.
  • Barclays analyst Adrienne Yih maintained an Overweight rating and cut the price target from $144 to $98 on Feb. 5, 2025. This analyst has an accuracy rate of 62%.
  • Wells Fargo analyst Ike Boruchow downgraded the stock from Overweight to Equal-Weight and slashed the price target from $130 to $105 on Feb. 3, 2025. This analyst has an accuracy rate of 70%.

Considering buying PVH stock? Here’s what analysts think:

Read This Next:

  • Jim Cramer: Healthpeak Properties Is A ‘Reasonable’ REIT, Recommends Buying This Health Care Stock

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.